![Patrick M. Schlievert](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Patrick M. Schlievert
Gründer bei Hennepin Life Sciences LLC
Profil
Patrick M.
Schlievert is the founder of ImmuVen, Inc. founded in 2008 and Hennepin Life Sciences LLC founded in 2009, where he holds the title of Director & Chief Scientific Officer.
Aktive Positionen von Patrick M. Schlievert
Unternehmen | Position | Beginn |
---|---|---|
Hennepin Life Sciences LLC
![]() Hennepin Life Sciences LLC Pharmaceuticals: MajorHealth Technology Hennepin Life Sciences LLC operates as a clinical-stage biotechnology company which focuses on identifying and developing antimicrobial therapeutics. It is advancing its novel antimicrobial, GML Gel, for local administration to prevent and treat CA-UTIs caused by ESKAPE pathogens in hospitals and long-term care centers. The company was founded by Patrick M. Schlievert, William Merrill Faulkner and Douglas Wicks in 2009 and is headquartered in Plymouth, MN. | Gründer | 01.01.2009 |
Ehemalige bekannte Positionen von Patrick M. Schlievert
Unternehmen | Position | Ende |
---|---|---|
ImmuVen, Inc.
![]() ImmuVen, Inc. Drugstore ChainsRetail Trade ImmuVen, Inc. develops drugs to treat viral diseases and cancer. The firm develops biotherapeutics to treat cancer, infectious disease, and autoimmune disorders. It’s platform allows rapid selection and optimization of T cell receptors with high affinity to targets in cancer, infections, and autoimmune pathways. The company was founded by David Kranz and Patrick M Schlievert in November 2008 and is headquartered in Champaign, IL. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
ImmuVen, Inc.
![]() ImmuVen, Inc. Drugstore ChainsRetail Trade ImmuVen, Inc. develops drugs to treat viral diseases and cancer. The firm develops biotherapeutics to treat cancer, infectious disease, and autoimmune disorders. It’s platform allows rapid selection and optimization of T cell receptors with high affinity to targets in cancer, infections, and autoimmune pathways. The company was founded by David Kranz and Patrick M Schlievert in November 2008 and is headquartered in Champaign, IL. | Retail Trade |
Hennepin Life Sciences LLC
![]() Hennepin Life Sciences LLC Pharmaceuticals: MajorHealth Technology Hennepin Life Sciences LLC operates as a clinical-stage biotechnology company which focuses on identifying and developing antimicrobial therapeutics. It is advancing its novel antimicrobial, GML Gel, for local administration to prevent and treat CA-UTIs caused by ESKAPE pathogens in hospitals and long-term care centers. The company was founded by Patrick M. Schlievert, William Merrill Faulkner and Douglas Wicks in 2009 and is headquartered in Plymouth, MN. | Health Technology |